1[1]Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:309-319.
2[2]Tsuda E, Goto M, Mochizuke S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun, 1997,234:137-142.
3[3]Tan KB, Harrop J, Reddy M, et al. Characterization of a noval TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997,204: 35-46.
4[4]Yasuda H, Shima N, Nakagawa N, et al. Identity of osteeclastogenesis inhibitory factor ( OCIF ) and osteoprotegerin ( OPG ): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology,1998, 139: 1329-1337.
5[5]Morinaga T, Nakagawa N, Yasuda H, et al. Cloning and characterizagion of the gene encoding human osteoprotegerin/osteoclastogenesis inhibitory factor. Eur J Biochem, 1998,254:685-691.
6[6]Yamaguchi K, Kinosaki M, Goto M, et al. Characterization of structured domains of human osteoclastogenesis inhibitory factor. J Biol Chem, 1998,273:5117-5123.
7[7]Tomoyasu A, Goto M, Fujise N, et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. Biochem Biophys Res Commun, 1998,245:382-387.
8[8]Tsukii N, Shima N, Mochizuki S, et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1α, 25-dihydroxyvitamin D3, prostaglandin F2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun, 1998,246: 337-341.
9[9]Akatsu T, Murakami T, Nishikawa M, et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun, 1998,250: 229-234.
10[10]Mizuno A, Amizuka N, Irie K, et al. Severe osteoporosis in mice lacking osteeclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun, 1998,247:610-615.
5Lacey DL,Timms E,Tan HL,et al.Osteoprotegerin ligand is acytokine that regulates osteoclast differentiation and activation[J].Cell,1998,93(2):165-176.
6Jiao K,Wang MQ,Niu LN,et al.Mandibular condylar cartilageresponse to moving 2 molars in rats[J].Am J Orthod DentofacialOrthop,2010,137(4):460.e1-e8.
7Katagiri T,Takahashi N.Regulatory mechanisms of osteoblast andosteoclast differentiation[J].Oral Dis,2002,8(3):147-159.
8Makhluf HA,Mueller SM,Mizuno S,et al.Age-related decline inosteoprotegerin expression by human bone marrow cells culturedin three-dimensional collagen sponges[J].Biochem Biophys ResCommun,2000,268(3):669-672.
9Sugiyama T.Involvement of interleukin-6 and prostaglandin E2 inperiarticular osteoporosis of postmenopausal women with rheuma-toid arthritis[J].J Bone Miner Metab,2001,19(2):89-96.
10Jiao K,Niu LN,Wang MQ,et al.Subchondral bone loss followingorthodontically induced cartilage degradation in the mandibularcondyles of rats[J].Bone,2011,48(2):362-371.
